Gilead Sciences
GILD
#129
Rank
S$194.99 B
Marketcap
S$157.15
Share price
-1.14%
Change (1 day)
28.57%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : S$32.33 Billion

According to Gilead Sciences's latest financial reports the company's total debt is S$32.33 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$36.30 B10.02%
2023-12-31S$33.00 B-2.43%
2022-12-31S$33.82 B-6.28%
2021-12-31S$36.08 B-13.13%
2020-12-31S$41.54 B25.3%
2019-12-31S$33.15 B-11.17%
2018-12-31S$37.32 B-16.8%
2017-12-31S$44.86 B17.65%
2016-12-31S$38.13 B22.22%
2015-12-31S$31.19 B90.35%
2014-12-31S$16.38 B94.94%
2013-12-31S$8.40 B-16.4%
2012-12-31S$10.05 B2.08%
2011-12-31S$9.85 B119.47%
2010-12-31S$4.48 B156.13%
2009-12-31S$1.75 B5.63%
2008-12-31S$1.65 B-12.11%
2007-12-31S$1.88 B-12.72%
2006-12-31S$2.16 B331.8%
2005-12-31S$0.50 B73888.52%
2004-12-31S$0.67 M-99.88%
2003-12-31S$0.58 B-43.19%
2002-12-31S$1.03 B121.59%
2001-12-31S$0.46 B5.39%
2000-12-31S$0.44 B202.03%
1999-12-31S$0.14 B-12.59%
1998-12-31S$0.16 B3006.03%
1997-12-31S$5.39 M-40.69%
1996-12-31S$9.09 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
S$70.76 B 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$2.37 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$89.12 B 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.33 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$8.54 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$78.88 B 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.37 B 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.10 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$53.63 B 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA